The role of firm characteristics in pharmaceutical product launches

RAND Journal of Economics

Volumn 37, Issue 3, 2006, Pages 602-618

  Kyle, Margaret K ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248374241     PISSN: 07416261     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1756-2171.2006.tb00033.x     Document Type: Review

References (40)

1. ALLISON, P. Event History Analysis: Regression for Longitudinal Event Data. Newbury Park, Calif.: Sage Publications, 1984.
2. AMEMIYA, T. Advanced Econometrics. Cambridge, Mass.: Harvard University Press, 1985.
3. BERNDT, E., BUI, L., LUCKING-REILEY, D., AND URBAN, G. "The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Antiulcer Drug Industry." In T.F. Bresnahan and R.J. Gordon, eds., The Economics of New Goods, Studies in Income and Wealth, Vol. 58. Chicago: University of Chicago Press, 1997.
4. BERRY, S. "Estimation of a Model of Entry in the Airline Industry." Econometrica, Vol. 60 (1992), pp. 889-917.
5. BRESNAHAN, T.F. AND REISS, P. "Do Entry Conditions Vary Across Markets?" Brookings Papers on Economic Activity: Microeconomics, 1987, pp. 833-871.
6. _ AND _. "Entry in Monopoly Markets." Review of Economic Studies, Vol. 57 (1990), pp. 531-553.
7. _ AND _. "Entry and Competition in Concentrated Markets." Journal of Political Economy, Vol. 99 (1991), pp. 977-1009.
8. CARPENTER, D. "The Political Economy of FDA Drug Approval: Processing, Politics and Policy Effects." Mimeo, Harvard University, 2003.
9. CAVES, R., WHINSTON, M.D., AND HURWITZ, M. "Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry." Brookings Papers on Economic Activity: Microeconomics, 1991, pp. 1-48.
10. COCKBURN, I. AND HENDERSON, R. "Racing to Invest? The Dynamics of Competition in Ethical Drug Discovery." Journal of Economics and Management Strategy, Vol. 3 (1994), pp. 481-519.
11. _ AND _. "Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery." Journal of Industrial Economics, Vol. 46 (1998), pp. 157-182.
12. DANZON, P. AND CHAO, L. "Cross-National Price Differences for Pharmaceuticals: How Large, and Why?" Journal of Health Economics, Vol. 19 (2000a), pp. 159-195.
13. _ AND _. "Does Regulation Drive Out Competition in Pharmaceutical Markets?" Journal of Law and Economics, Vol. 43 (2000b), pp. 311-357.
14. _, WANG, Y.R., AND WANG, L. "The Impact of Price Regulation on the Launch Delay of New Drugs." Health Economics, Vol. 14 (2005), pp. 269-292.
15. DIMASI, J. "New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical Firms." Drug Information Journal, Vol. 34 (2000), pp. 1169-1194.
16. _, HANSEN, R.W., AND GRABOWSKI, H.G. "The Cost of Innovation in the Pharmaceutical Industry." Journal of Health Economics, Vol. 10 (2003), pp. 107-142.
17. DIXIT, A. AND STIGLITZ, J. "Monopolistic Competition and Optimal Product Diversity." American Economic Review, Vol. 67 (1977), pp. 297-308.
18. DJANKOV, S., LA PORTA, R., LOPEZ-DE-SILANES, F., AND SHLEIFER, A. "The Regulation of Entry." Quarterly Journal of Economics, Vol. 117 (2002), pp. 1-38.
19. DRANOVE, D. AND MELTZER, D. "Do Important Drugs Reach the Market Sooner?" RAND Journal of Economics, Vol. 25 (1994), pp. 402-423.
20. ELLISON, S., COCKBURN, I., GRILICHES, Z., AND HAUSMAN, J. "Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins." RAND Journal of Economics, Vol. 28 (1997), pp. 426-446.
21. GRABOWSKI, H. AND VERNON, J. "Brand Loyalty, Entry and Price Competition in Pharmaceuticals After the 1984 Drug Act." Journal of Law and Economics, Vol. 35 (1992), pp. 331-350.
22. HENDERSON, R. AND COCKBURN, I. "Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery " RAND Journal of Economics, Vol. 27 (1996), pp. 32-59.
23. HUDSON, J. "Generic Take-up in the Pharmaceutical Market Following Patent Expiry: A Multi-country Study." International Review of Law and Economics, Vol. 20 (2000), pp. 205-221.
24. IMS HEALTH. Country Sales Report, 2000.
25. JACOBZONE, S. "Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals." OECD Labour Market and Social Policy Occasional Paper no. 40, 2000.
26. KYLE, M. "Pharmaceutical Price Controls and Entry Strategies." Review of Economics and Statistics, Vol. 89 (2007), pp. 88-99.
27. LANJOUW, J. "Patents, Price Controls and Access to New Drugs: How Policy Affects Global Market Entry." NBER Working Paper no. 11321, 2005.
28. LICHTENBERG, F. AND PHILIPSON, T. "The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the U.S. Pharmaceuticals Industry." Journal of Law and Economics, Vol. 45 (2002), pp. 643-672.
29. MANKIW, N.G. AND WHINSTON, M.D. "Free Entry and Social Inefficiency." RAND Journal of Economics, Vol. 17 (1986), pp. 48-58.
30. MAZZEO, M. "Product Choice and Oligopoly Market Structure." RAND Journal of Economics, Vol. 33 (2002), pp. 221-242.
31. MERCK MANUAL OF DIAGNOSIS AND THERAPY, www.merck.com/mmpe/.
32. OECD JOINT GROUP ON TRADE AND COMPETITION. "Synthesis Report on Parallel Imports." Paris: OECD Publications, 2001.
33. PARKER, J. The International Diffusion of Pharmaceuticals. London: Macmillan Press, 1984.
34. PERRY, M. "Scale Economies, Imperfect Competition, and Public Policy." Journal of Industrial Economics, Vol. 32 (1984), pp. 313-330.
35. SCOTT MORTON, F. "Entry Decisions in the Generic Pharmaceutical Industry." RAND Journal of Economics, Vol. 30 (1999), pp. 421-440.
36. SPENCE, A.M. "Product Selection, Fixed Costs, and Monopolistic Competition." Review of Economic Studies, Vol. 43 (1976), pp. 217-236.
37. STERN, S. "Market Definition and the Returns to Innovation: Substitution Patterns in Pharmaceutical Markets." MIT POPI Working Paper, 1996.
38. THOMAS, L.G. "Implicit Industrial Policy: The Triumph of Britain and the Failure of France in Global Pharmaceuticals." Industrial and Corporate Change, Vol. 2 (1994), pp. 451-489.
39. TOIVANEN, O. AND WATERSON, M. "Market Structure and Entry: Where's the Beef?" Mimeo, University of Warwick, 2001.
40. VON WEIZÄCKER, C. "A Welfare Analysis of Barriers to Entry." Bell Journal of Economics, Vol. 11 (1980), pp. 399-420.